Neuralink, billionaire Elon Musk’s brain chip company, announced that it has received approval from an independent review board to begin the first human test of its brain implant for paralysis patients.
The study aims to test the safety and effectiveness of Neuralink’s wireless, implantable brain-computer interface, designed to allow people with paralysis to control external devices with their minds.
During the trial, a surgical robot will be used to place ultra-thin, flexible threads from the implant into a region of the brain that controls movement intention.
“Once inserted, the implant is aesthetically invisible and is designed to record and wirelessly transmit brain signals to an application that deciphers the intent of the movement,” the company explained in a blog.
He added that the original goal of the interface was to give people the ability to control a computer’s cursor or keyboard using just their thoughts.
According to Neuralink, patients with paralysis due to cervical spine injury or amyotrophic lateral sclerosis can take part in the study.
On the social network X, the company announced that it was open to recruiting patients for its first human clinical trial.
“If you have quadriplegia due to a cervical spine injury or amyotrophic lateral sclerosis (ALS), you may be eligible,” he says.